This study employs network pharmacology and animal models to investigate how the modified Jinshui Liujian decoction combined with Bajitian pills modulates the Nrf2/Heme oxygenase-1 (HO-1) pathway to mitigate muscle atrophy in a mouse model of COPD. The gene discussed is HMOX1; the disease is chronic obstructive pulmonary disease.